Published in Proteomics Weekly, January 19th, 2004
"To evaluate the persistence of the immune response in a population of healthy volunteers that had been vaccinated with a new Hansenula polymorpha recombinant hepatitis B vaccine in a previous clinical study 4 years before, we measured the titer of anti-HBs," investigators in Argentina report.
"All, but one of the evaluated volunteers remained protected," said Alejandro Lepetic at the Fundacion del Centro de Estudios Infectologicos in Buenos Aires and collaborators in Argentina. "None of them...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.